NASDAQ · Health care

Apnimed, Inc. (APMD)

At June 30, 2026 it held $172.8M in cash against $40.3M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on September 8, 2026.

Watch APMD in 60 seconds

Price

$15.81

+4.70% on the day · November 9, 2026

52-week range $13.88 to $35.29

Market cap

$600.8M

Key facts about Apnimed, Inc.

Net worth: Apnimed, Inc. has a market value (market cap) of $600.8M at the latest share price. A company's "net worth" usually means this market value or the shareholders' equity on its balance sheet.
Latest report: The latest periodic report (quarterly report, 10-Q) was filed with the SEC on September 8, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR

What Apnimed, Inc. does

Apnimed, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker APMD.

Earnings: every quarter and the next report date

Latest SEC filings

What Apnimed, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

November 4, 2026
Passive stake (5% or more) SCHEDULE 13G
September 8, 2026
Employee stock plan registration S-8
September 8, 2026
Quarterly report 10-Q · period to June 30, 2026Revenue fell 29% to $12.1M versus the same quarter last year; net income of $125.9M versus a net loss of $69.5M.
September 8, 2026
Quarterly results 8-K
August 7, 2026
Passive stake (5% or more) SCHEDULE 13G
August 6, 2026
Passive stake (5% or more) SCHEDULE 13G
August 3, 2026
Bylaws or fiscal year changed 8-K
July 31, 2026
Employee stock plan registration S-8
July 30, 2026
Form S-1MEF filing S-1MEF
July 27, 2026
IPO registration (amended) S-1/A

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 5, 2026. Insider transactions on SEC

Insider trades

What the people running Apnimed, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)

last 90 days

Sold

last 90 days

Date	Insider	What	Shares	Price	Value	Filing
August 3, 2026	Morningside Venture Investments Ltd10% owner	Exercised options	6,840,213	-	-	Form 4
August 3, 2026	Morningside Venture Investments Ltd10% owner	Other change	6,840,213	-	-	Form 4
August 3, 2026	Morningside Venture Investments Ltd10% owner	Other change	6,840,213	-	-	Form 4
August 3, 2026	Morningside Venture Investments Ltd10% owner	Bought	312,500	$16.00	$5M	Form 4
August 3, 2026	Morningside Venture Investments Ltd10% owner	Exercised optionsindirect	75,624	$14.40	$1.1M	Form 4
August 3, 2026	Morningside Venture Investments Ltd10% owner	Other changeindirect	75,624	-	-	Form 4
August 3, 2026	Morningside Venture Investments Ltd10% owner	Other changeindirect	75,624	-	-	Form 4
August 3, 2026	Alpha Wave Ventures GP, Ltd10% owner	Exercised optionsindirect	1,001,651	-	-	Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns APMD

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Holder	Of class	Shares	Filed
Shionogi & Co Ltd13G, passive	7.1%	2,953,817	November 4, 2026
Tao Capital Management LP13G, passive with 2 related filers	5.2%	2,178,138	August 6, 2026

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

5 insiders reported holding 14,442,761 shares in total, about $228.3M at the last price.

Holder	Shares	As of
Morningside Venture Investments Ltd10% owner	7,228,33775,624 held indirectly	August 3, 2026
Alpha Wave Ventures GP, Ltd10% owner	7,054,9567,054,956 held indirectly	August 3, 2026
Miller Lawrence G.Director	88,95488,954 held indirectly	August 3, 2026
Molnar Dennis PatrickPresident	58,014	August 3, 2026
Sekhri Paul JDirector	12,500	August 3, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about APMD

What does Apnimed, Inc. do?

Apnimed, Inc. is a company in the Health care sector, listed on NASDAQ as APMD. Its shares trade on NASDAQ under the ticker APMD.

What is Apnimed, Inc.'s net worth?

Apnimed, Inc. has a market value (market cap) of $600.8M at the latest share price. A company's "net worth" usually means this market value or the shareholders' equity on its balance sheet.

When did Apnimed, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on September 8, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake (5% or more) from November 4, 2026.

Similar companies

Assembly Biosciences, Inc.

ALT

Altimmune, Inc.

SPRY

ARS Pharmaceuticals, Inc.

NVCT

Nuvectis Pharma, Inc.

Compare APMD with

Compare APMD with any company

Follow APMD

Get an email when Apnimed, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Where the numbers come from

Financial figures are the values Apnimed, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.